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Stent implantation to relieve branch pulmonary artery stenosis (BPAS) is an
alternative to failed surgical or balloon angioplasty. From April 1992 to August
1994,26 patients underwent an attempt at stent implantation (11 in Boston;
group 1 and 15 in Riyadh; group 2). The two groups median age was 7.6
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The expanding role of combined catheter and surgical therapies for complex
congenital cardiac defects has led to wider application of pulmonary artery
(PA) angioplasty. However remarkably little information is available on the
fate of previously dilated pulmonary arteries. We undertook this study to
determine the frequency and predictabilityof restenosis after PA angioplasty.
All PA dilations performed from 1/90 to 12/93 at Children's Hospital were
reviewed to determine initial success la. :;:50% increase in stenosis diam-
eter; b. >20% decrease in the ratio of right ventricular to aortic pressure
(intact ventricular septum); or C. :;:20% increase in lung perfusion). Initial
and followup up catheterization data for successful dilations (based on an-
giogra phic criteria only) were then reviewed to determine patient age and
diagnosis; etiology of stenosis; balloon size, type, inflation pressure; com-
plications; and diameters of the stenosis and distal vessel pre and post dila-
The Bard Clamshell Septal Occluder Device has been used to close various
congenital defects. Little is known about the long term biological response
to device placement. The original Bard Clamshell® Septal Occluder Device
(00) has been revised to decrease the risk of arm fractures. This study eval-
uates and compares the long term response to placement of the new Bard
Clamshell II Septal Occluder Device (BSO) and the 00. Twenty three dogs
underwent blade atrial septostomy followed by balloon dilation. A 23 mm
device was deployed 2 weeks later to close the ASD. Dogs were evaluated
angiographically at 1 month, 3 month, 6 month, 1 year and 2 year intervals.
A portion of the dogs were sacrificed at each of these intervals. Explant x-
rays, gross and microscopic evaluation were then performed on the excised
heart. Ten dogs underwent placement of the 00, and thirteen dogs the BSO.
In the 00 group, 1/10 dogs had an arm fracture between 3 and 6 months af-
ter placement. In the SSO group, 0/13 dogs had arm fractures. There was no
evidence of thrombus formation in either group on angiographic follow-up
or pathologic evaluation. By one month, in both groups, the device was at
least 50% endothelialized with a normal healing response. Scanning electron
microscopy ISEM) showed neointima formation with an endothelialized sur-
face. There was generally a focal foreign body reaction with macrophages
and foreign body giant cells at the tissue/device interface. Focal areas of
capillary formation in developing granulation tissue were seen within the fi-
brosed edges of the device, and were secondary to a rigid device within
moving tissue. The device was completely endothelialized by 3 months. At
six months, there was normal healing in both groups. In the 00 group, mi-
croscopic calcium deposition was noted in 2/2 dogs sacrificed at one year.
Gross evaluation on the two year 00 dogs showed normal healing. One year
and two year dogs in the BSO group (3/3 each) are awaiting sacrifice. In both
groups, SEM indicated no evidence of metal corrosion or fatigue. In conclu-
sion, appropriately placed Clamshell Occluder devices are well tolerated up
to 2 years in the canine heart with complete endothelialization by 3 months
post-implantation. There are no significant differences up to 6 months in the
healing response between the old and new device designs. The new devices
have not fractured to date.
years (range 1.3 - 64 years). 20/26 were post surgical repair of tetralogy of
Fallot, two patients after Fontan operation, two with native BPAS, and one
each with Williams syndrome and Alagille syndrome. A total of 37 stents
were implanted successfully in 25 patients (16 in group 1 and 21 in group 2).
The systolic gradient across the stenosis fell from a median of 40 ± 22 to 9
± 6 mmHg, p < 0.001 and the diameter of the narrowest segment improved
from 4.7 ± 0.4 to 10.8 ± 0.4 mm, p < 0.001. The right ventricle to aortic pres-
sure ratio fell from 0.68 to 0.49, P < 0.001. The median fluoroscopy time was
150 ± 20 minutes. Complications included 2 patients where the balloon rup-
tured prior to full stent inflation, one stent was positioned in the superior vena
cava and the other in the inferior vena cava. No other complications. Quanti-
tative lung perfusion scan was performed pre and post stent deployment in
9 patients. This showed significant improvement of pulmonary blood flow in
patients receiving unilateral stent. Patients were maintained on aspirin alone
in group 1 and aspirin with dipyridamole in group 2. 10 patients underwent
repeat cardiac catheterization at a mean follow-up interval of 15 months. The
gradient across the stent remained low at 20 ± 4 mmHg and there was no
change in the diameter (11 ± 0.5 mm). One patient developed significant
restenosis secondary to intimal proliferation at the stent site, this was redi-
lated successfully. We conclude that balloon expandable stents are safe and
effective in relieving BPAS. Stents should be considered the treatment of
choice for most patients with BPAS.
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Fontan conduit or baffle stenosis may lead to elevated right sided pressures,
poor exercise tolerance, chronic effussions and/or atrial arrhythmias (AA).
Since these findings may also occur independently post Fontan, we report a
group of 14 patients who underwent balloon dilation (BD) and/or stent place-
ment (SP) of stenotic Fontan conduits or baffles.
From 1/87 to 6/94, 18 procedures (10/18 SP; 8/18 BD) were performed
in 14 patients (pts) with Fontan baffle or conduit stenosis, aged 1.3 to 39.4
years (21 .6 ± 11.8 y). Diagnoses were tricuspid atresia (12/14), single ventri-
cle (1/14) and ma laligned complete atrioventricular canal (1/14). The previous
Fontan procedures included a right atrium (RA) to pulmonary artery (PA) con-
duit in 11, atriopulmonary anastomosis (APA) in 2 and a lateral tunnel (LT)
Fontan in 1. All pts had decreased cardiac index ICI) and poor exercise tol-
erance; 7/14 had AA; 1/14 had chronic effussions. At catheterization, 4 pts
underwent BD only. Ten pts had 13 iliac stents (30 mm) placed (12 in con-
duits and 1 in a stenotic APA). The balloonlvessel ratio was 3.0 ± 1.2. There
was no mortality with the procedure. One pt died 1.6 y later following con-
version to a LT Fontan. Complications were AA requiring cardioversion (3/14),
migration of a stent to the RA (1/14) which was retrieved in the cath lab and
misplacement of a stent in the proximal left PA. Following BD and/or SP: 1)
mean vessel diameter increased from 7.4 mm ± 3.6 mm to 11.7 ± 4.4 (p <
0.01); 2) the mean gradient at stenotic baffle or conduit changed from 7.9 ±
6 mmHg to 2.6 mmHG ± 3.39 (p < 0.005); 3) the mixed venous saturation
changed from 51% ± 11 to 59% ± 12 (p < 0.01); 4) mean RA pressures
changed from 20 ± 6 mmHg to 16.6 ± 4 (p < 0.01); 5) CI changed from 1.8
± 0.6I1min/m2 to 2.5 ± 1.1 IImin/m2 (p < 0.06). At follow up (1.3 ± 1.1 y)
4 pts had no symptomatic improvement and underwent conduit change (1),
conversion to a LT (2) and Fontan take-down (1). Eight pts had symptomatic
improvement, with 2/14 lost to follow-up.
Conclusion; BD and/or stent placement of stenotic Fontan baffles or con-
duits improves hemodynamics and often provides short term symptomatic
benefit.
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We describe our experience with nonsurgical closure of coronary artery fis-
tulae (CAF) using a transcatheter approach and Gianturco coils. Since 7/92 6
patients (pts) age 9 to 22 years (mean = 14.5) were referred for evaluation
and treatment of CAF. Two were symptomatic with chest pain and a third
had dyspnea on exertion. Catheterization was performed from the femoral
region using IV sedation in 5, and general anesthesia in 1. Selective coronary
angiograms were performed in all pts followed by hand or power injections
within the fistulas themselves. Angled views were employed to detail fistula
anatomy as well as to visualize coronary artery branches. Catheters were
manipulated into each fistula from a retrograde aortic approach. Temporary
balloon occlusion of the fistula with EKG monitoring was performed in 5.
Coils were placed through an end hole catheter positioned distally within
the fistula.
Each pt had asingle fistula. Two CAF arose from the LAD: 1drained into the
RV and 1 into the RA. One CAF arose from the circumflex artery and drained
into the RV Three CAF arose from the RCA: 2 drained into the RA and 1
into the RV Temporary balloon occlusion in one pt resulted in significant ST
segment changes and aided in the identification of the origin of the poste-
rior descending artery adjacent to the fistulous connection to the RV Coil
embolization was not attempted in this pt. The remaining 5 pts underwent
successful complete occlusion of the CAF using multiple (2 to 16) Gianturco
coils. There were 2 coil embolizations to the pulmonary artery with success-
ful retrieval of 1. At follow-up (1-15 months, mean = 11) all pts are asymp-
tomatic with no clinical or echocardiographic evidence of recanalization or
residual shunts. Transcatheter closure is the preferred method to safely and
effectively close most CAF.
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